Sandoz Calls for EU Probe into Alleged China Drug Dumping

Generics drugmaker Sandoz, a Novartis spin-off, has urged the EU to investigate alleged dumping practices by China, claiming that Chinese overcapacity threatens European self-reliance and access to key antibiotics.